Low-dose progestagens as contraceptive agents.
Elstein
M
M
D001695:Biology; D002582:Cervix Mucus; D002584:Cervix Uteri; D002715:Chlormadinone Acetate; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D004703:Endocrine System; D004717:Endometrium; D005040:Ethynodiol Diacetate; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D006728:Hormones; D019290:Megestrol Acetate; D009640:Norethindrone; D010053:Ovary; D010342:Patient Acceptance of Health Care; D010827:Physiology; D045167:Progesterone Congeners; D014566:Urogenital System; D014599:Uterus
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D006728:Hormones; D045167:Progesterone Congeners; D002715:Chlormadinone Acetate; D005040:Ethynodiol Diacetate; D009640:Norethindrone; D019290:Megestrol Acetate
Biology; Cervical Mucus; Cervix; Chlormadinone Acetate--side effects; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods--pharmacodynamics; Contraceptive Methods--side effects; Contraceptive Usage; Endocrine System; Endometrial Effects; Endometrium; Ethynodiol Diacetate--side effects; Family Planning; Genitalia; Genitalia, Female; Gonadotropins; Gonadotropins, Pituitary; Hormones; Megestrol Acetate--side effects; Method Acceptability; Norethindrone Acetate--side effects; Norethindrone--side effects; Oral Contraceptives--pharmacodynamics; Oral Contraceptives--side effects; Ovarian Effects; Ovary; Physiology; Progestins, Low-dose--side effects; Urogenital System; Uterus